Technology News and Research

RSS

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.

23 Sep 2009

ID Analytics' risk management solutions available on U.S. GSA Schedule

ID Analytics, Inc., the leader in on-demand identity intelligence, announced today its risk management solutions are now available on its' U.S. General Services Administration (GSA) Schedule.

23 Sep 2009

GE Healthcare creates a digital wall to commemorate the tenth anniversary of digital mammography

In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare (NYSE:GE) in 1999. Similar to digital photography, digital mammography replaces the film used in traditional mammography with digital files viewed and stored on computers.

23 Sep 2009

KARL STORZ receives LEED Silver certification

KARL STORZ Endoscopy-America, Inc., a leader in diagnostic and operative minimally invasive endoscopic technology, is proud to announce that it has been awarded LEED® (Leadership in Energy and Environmental Design) Silver certification from the U.S. Green Building Council (USGBC) for the company’s North American Headquarters.

23 Sep 2009

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Today, Scott Livingston, CEO and Founder of Livingston Securities (www.livingstonsecurities.com) announced the agenda for the 2nd Annual Livingston Healthcare and Life Science Stakeholders Summit.

23 Sep 2009

Safeguard Scientifics sells additional 2.4 million shares of its position in Clarient

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it has sold an additional 2.4 million shares of its position in Clarient, Inc. (Nasdaq: CLRT) through a Clarient shelf registration on Form S-3 that was declared effective by the Securities and Exchange Commission on August 20, 2009.

23 Sep 2009

The Freeplay Foundation's Lifeline radio and Lifelight programs to benefit poor women in Rwanda

The Freeplay Foundation announced today that it has been chosen as a featured organization at this week's meeting of the Clinton Global Initiative. The Foundation has pledged its intent to integrate the award-winning Freeplay Lifeline radio and new clean energy Lifelight into a program benefiting 20,000 extremely poor women and girls across Rwanda.

23 Sep 2009

Agilent Technologies introduces SureSelect Human All Exon Kit

Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute’s Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.

23 Sep 2009

Agilent Technologies and Applied Biosystems to co-market SureSelect system

Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a next-generation advanced genomic analysis sequencing platform.

23 Sep 2009

UBC acquires Gigamoto Technology Partners to implement risk management programs

United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry.

23 Sep 2009

Benefitfocus and USAble Life announce multi-year partnership

Benefitfocus® and USAble Life announced today a multi-year partnership through 2013 that leverages the Benefitfocus suite of solutions to transform the way group and voluntary benefits are sold, enrolled, billed and serviced.

23 Sep 2009

NIH funding helps to boost sales of DNA sequencers

Rapid increase in output from second-generation DNA sequencers has enabled new levels of productivity and new experiments. This, along with funding from the stimulus bill, has caused rapid adoption of these machines, according to healthcare market research firm Kalorama Information, helping to fuel sales of DNA sequencers to $480 million in 2008. In its report "DNA Sequencing Equipment and Services Markets, 2nd Edition," Kalorama says more changes are on the way and will drives sales growth of 19% annually through 2013.

23 Sep 2009

SynCardia Systems and AorTech International sign technology license agreement

On Sept. 22, SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, announced an exclusive technology licensing agreement with AorTech International plc (AIM: AOR).

23 Sep 2009

EU-U.S. trans-disciplinary research agenda for synthetic biology

The Wilson Center's Synthetic Biology project recently received two grants from the National Science Foundation. One will support a Transatlantic Exploratory Workshop on the Implications of Cutting-Edge Biotechnologies for Sustainability Science and Policy, and the other will support research on the use of on-line prediction markets to explore emerging issues in synthetic biology.

23 Sep 2009

Niti Surgical Solutions receives patent certificates for Hand CAC 30 and CAR 31 in Japan and China

NiTi Surgical Solutions, an innovative surgical device company, today announced the Japan Patent Office and the Patent Office of China have issued patent certificates that cover two of the company’s products, the Hand CAC™ 30 Compressions Anastomosis Clip applicator and CAR™ 31 Compression Anastomosis Ring.

23 Sep 2009

Technological and scientific initiatives from Helicos BioSciences Corporation

Helicos BioSciences Corporation provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an overview of recent technological and scientific initiatives underway at Helicos.

23 Sep 2009

Norman Noble to use Raydiance Corporation's Smart Light ultrafast platform

Raydiance Corporation, developer of the world’s first commercial-grade ultrafast laser, announced today that its Smart LightTM ultrafast platform will provide the core technology for an advanced laser machining process, Noble UltraLightTM, to be launched by leading contract manufacturer Norman Noble, Inc. The Noble UltraLightTM process will enable highly precise, athermal machining of bio-absorbable materials, shape memory metals and other exotic materials for the medical device industry.

23 Sep 2009

Culligan and Good Housekeeping Seal celebrate 100th anniversary

In celebration of the 100th birthday of the Good Housekeeping Seal, the magazine’s famous emblem of quality and a limited two-year warranty, the magazine has created an interactive, traveling exhibit that recreates the Good Housekeeping Research Institute, where all product evaluations are conducted.

23 Sep 2009

StemCells pushing forward its SC Proven cell culture product business

StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company’s ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company’s Cambridge, UK and Palo Alto, California locations.

23 Sep 2009

NIST collaborates with private industry to release a new reference material for beryllium

Researchers at the National Institute of Standards and Technology (NIST), in collaboration with private industry and other government agencies, have produced a new reference material for beryllium. Beryllium, an exotic rare-earth metal used as a hardener in high-performance alloys and ceramics, can cause berylliosis-a chronic, incurable and sometimes fatal illness.

23 Sep 2009

Technology News and Research

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

ID Analytics' risk management solutions available on U.S. GSA Schedule

GE Healthcare creates a digital wall to commemorate the tenth anniversary of digital mammography

KARL STORZ receives LEED Silver certification

Livingston Securities announces the agenda for the 2nd Annual Livingston Healthcare Summit.

Safeguard Scientifics sells additional 2.4 million shares of its position in Clarient

The Freeplay Foundation's Lifeline radio and Lifelight programs to benefit poor women in Rwanda

Agilent Technologies introduces SureSelect Human All Exon Kit

Agilent Technologies and Applied Biosystems to co-market SureSelect system

UBC acquires Gigamoto Technology Partners to implement risk management programs

Benefitfocus and USAble Life announce multi-year partnership

NIH funding helps to boost sales of DNA sequencers

SynCardia Systems and AorTech International sign technology license agreement

EU-U.S. trans-disciplinary research agenda for synthetic biology

Niti Surgical Solutions receives patent certificates for Hand CAC 30 and CAR 31 in Japan and China

Technological and scientific initiatives from Helicos BioSciences Corporation

Norman Noble to use Raydiance Corporation's Smart Light ultrafast platform

Culligan and Good Housekeeping Seal celebrate 100th anniversary

StemCells pushing forward its SC Proven cell culture product business

NIST collaborates with private industry to release a new reference material for beryllium

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News